Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesVaccine potentials of an intrinsically unstructured fragment derived from the blood stage associated P. falciparum protein PFF0165c
Infection and Immunity, 10/19/09
Olugbile S et al. – The immunological properties of P27A together with its low polymorphism and association with clinical protection from malaria in human warrant its further development as a malaria vaccine candidate.
G Corradin, 11/05/09
| This is the first example of a candidate malaria vaccine identified by searching the malaria genome for red blood cell associated malaria proteins containing simple protein structural motifs and further down selected through a stringent selection procedure. The overall approach is very rapid and took 1-2 years from discovery to the clinics. |
Related Articles
CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09
Relevance Score: 99%
A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
British Journal of Cancer, 10/09/09
Relevance Score: 97%
One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09
Relevance Score: 97%
Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-Reported Barriers to Vaccination
Journal of Women's Health, 10/05/09
Relevance Score: 96%
H1N1 Vaccine Deliveries Begin. Early Doses to Arrive This Week
American Family Physician, 10/07/09
Relevance Score: 95%
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years : The Lancet
The Lancet - Early Online Publication, 12/03/09
Vaccine safety: current systems and recent findings
Current Opinion in Pediatrics, 12/03/09
Patterns of Influenza Vaccination among Medical Students
Infection Control and Hospital Epidemiology, 12/03/09
Sponsor
Article Search
Sponsor